Researchers at Kumamoto University have developed a highly sensitive blood test that can detect subtle differences in how easily blood begins to clot, offering new possibilities for tailoring ...

A doctor explains what happens to your blood and body after donation, including how volume is restored, how long recovery takes, and the biological processes that begin immediately once blood is drawn ...

The start-up Function will send practically anyone to a lab for extensive medical testing, no physical required. Is that a good thing? By Kristen V. Brown As Kimberly Crisp approached middle age, ...

NASHVILLE, Tenn. (WSMV) - Tennessee DUI laws are changing in the New Year. There are several new laws going into effect on January 1 regarding various issues, including driving under the influence.

Alzheimer’s disease blood test developer Quanterix put forward new clinical data from its Simoa assay, which it described as the largest population-based assessment of the condition’s ...

In a recent study, people with osteoporosis had higher levels of alkaline phosphatase (ALP) in their blood compared to patients who didn’t have osteoporosis. The link was strongest in young women with ...

Dec. 2 (UPI) --As new blood tests capable of detecting dozens of cancers in their early stages are hitting the market, disease prevention advocates say political and economic momentum is building for ...

Beyond the myriad complications that come with diabetes, patients have to additionally put up with regular blood sugar testing – which involves either multiple pin pricks a day to draw blood or ...

John Ferguson does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

Cancerguard detects multiple cancers early by identifying specific DNA and protein markers in a blood sample. The test is available for adults aged 50-84 without cancer in the past three years, but it ...

DEAR DR. ROACH: My husband was diagnosed with chronic lymphocytic leukemia (CLL) in 2010 and remained in stage 2 with no effects until 2022. In the interim, he was also diagnosed with atrial ...

A blood-based biomarker test, PancreaSure, demonstrated high sensitivity and specificity in differentiating patients with early-stage pancreatic ductal adenocarcinoma (PDAC) from control individuals ...